loadpatents
Patent applications and USPTO patent grants for Liu; Sihao.The latest application filed is for "fibroblast growth factor 1 (fgf1) mutant proteins that selectively activate fgfr1b to reduce blood glucose".
Patent | Date |
---|---|
Fibroblast Growth Factor 1 (fgf1) Mutant Proteins That Selectively Activate Fgfr1b To Reduce Blood Glucose App 20210032303 - Evans; Ronald M. ;   et al. | 2021-02-04 |
Use Of Fibroblast Growth Factor 1 (fgf1)-vagus Nerve Targeting Chimeric Proteins To Treat Hyperglycemia App 20190276510 - Evans; Ronald M. ;   et al. | 2019-09-12 |
Fibroblast Growth Factor (fgf) 1 Proteins With Glucose Lowering Ability And Reduced Mitogenicity App 20190151416 - Evans; Ronald M. ;   et al. | 2019-05-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.